A Prospective, Multicentre, Open-Label Single-Arm Exploratory Study to Evaluate Efficacy and Safety of Saroglitazar on Hypertriglyceridemia in HIV Associated Lipodystrophy.

A Prospective, Multicentre, Open-Label Single-Arm Exploratory Study to Evaluate Efficacy and Safety of Saroglitazar on Hypertriglyceridemia in HIV Associated Lipodystrophy.

OBJECTIVE:This study was designed to explore the efficacy and safety of saroglitazar 4 mg on hypertriglyceridemia in patients with HIV associated lipodystrophy. METHODS:During this 12-week prospective, multi-centric, open-label, single arm exploratory study, 50 patients were enrolled to receive saro...

Full description

Bibliographic Details
Main Authors: Alka Deshpande, Harsh Toshniwal, Shashank Joshi, Rajendrakumar H Jani
Format: Article
Language:English
Published: Public Library of Science (PLoS) 2016-01-01
Series:PLoS ONE
Online Access:http://europepmc.org/articles/PMC4720399?pdf=render

Similar Items

Similar Items